Results 41 to 50 of about 312,011 (322)

Examining the Utility of Social Media in COVID-19 Vaccination: Unsupervised Learning of 672,133 Twitter Posts

JMIR Public Health and Surveillance, 2021
BackgroundAlthough COVID-19 vaccines have recently become available, efforts in global mass vaccination can be hampered by the widespread issue of vaccine hesitancy.
Tau Ming Liew, Cia Sin Lee
doaj   +1 more source

Racing against COVID-19: a vaccines strategy for Europe. Bruegel Policy Contribution Issue n˚7 | April 2020 [PDF]

, 2020
The fast development of vaccines is an essential part of the long-term solution to COVID-19, but vaccine development has high costs and carries the risk of high failure rates.
Veugelers, Reinhilde, Zachmann, Georg.
core   +1 more source

How consumers decide to buy during the pandemic Covid-19? [PDF]

, 2022
A pandemic is a deadly disease that threatens society by spreading complex diseases and eventually spreads to other communities and areas. History shows that the world was once attacked by the flu pandemic, also known as the Spanish Flu, in 1918. The
Harun, Amran, Hasim, Muhammad Asyraf, Nordin, Muhammad Iqbal   +2 more
core  

Public Willingness to Receive COVID-19 Vaccines in Saudi Arabia

Journal of High Institute of Public Health, 2021
Background: COVID-19 vaccination is a crucial public health intervention to stem the pandemic, however, there is a public hesitation to take the vaccine all over the world because of concerns about safety.
Abdullah Alqathami, Noha S. Mohamed
doaj   +1 more source

Cognitive Factors Influencing COVID-19 Vaccination Intentions: An Application of the Protection Motivation Theory Using a Probability Community Sample

Vaccines, 2021
COVID-19 vaccines have been shown to provide protection against severe disease and death. However, substantial individual differences in vaccination intentions have hindered achieving optimal vaccination rates across the population. To look for efficient
Kwok Kit Tong, Mu He, Anise M. S. Wu, Le Dang, Juliet Honglei Chen   +4 more
doaj   +1 more source

Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca [PDF]

, 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its extraordinary meeting on 8 February 2021 (1). Declarations of interests were collected from all external
WHO SAGE Working Group on COVID-19 Vaccines
core  

HIV infection and the implication for COVID‐19 vaccination

Public Health Challenges, 2022
Human immunodeficiency virus (HIV) is associated with altered cellular and humoral immune response, especially in patients with an untreated or chronic infection.
Tope Oyelade, Reynie Purnama Raya, Kamaluddin Latief   +2 more
doaj   +1 more source

Comparison of the post-marketing safety profile between influenza and COVID-19 vaccines: An analysis of the vaccine adverse event reporting system

Saudi Pharmaceutical Journal, 2022
The global coronavirus disease (COVID-19) epidemic can be partially managed by vaccines; however, the public must be informed about the safety of COVID-19 vaccines to avoid hesitancy.
Abdullah K. Al-Ahmari, Amnah AlAsmari, Anoud AlKorbi, Nehad J Ahmed, Ziyad S. Almalki, Ahmed M. Alshehri, Ahmed A. Albassam, Ghada M. Alem   +7 more
doaj   +1 more source

Emerging respiratory viral infections: MERS-CoV and influenza [PDF]

, 2014
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Tawfiq, Jaffar A., Memish, Ziad A.
core   +1 more source

COVID-19 vaccination and long COVID-19 [PDF]

Reviews in Clinical Medicine
According to the literature, COVID-19 vaccines reduce long COVID-19 symptoms such as cognitive dysfunction, kidney diseases, myalgia, and sleeping disorders (5-7).
Ava Ghezel, Chista Arfaee
doaj   +1 more source